Saturday, March 22, 2025
9:30 AM to 1:30 PM Pacific Time
Myeloma Rounds San Francisco
Hyatt Regency San Francisco
Garden Room
5 Embarcadero Center
San Francisco, California 94111
LLS will cover parking for practicing healthcare professionals only. Additional details will be provided in the reminder email.
*Only one (1) person per medical technology/pharmaceutical company may register and attend the Rounds. A corporate email address is required.
Agenda
9:30 AM – Brunch and Networking
10:00 AM – Welcome and Overview of Program
Ajai Chari
10:10 AM – Overview of LLS Resources, including the Clinical Trial Support Center
Ashley Giacobbi
10:20 AM – Newly Diagnosed Multiple Myeloma: Case and Discussion
Lekha Mikkilineni and Yonatan Cooper
11:30 AM – Treating Early Relapsed Multiple Myeloma with CAR-T: Case and Discussion
Jodi Lipof and Meryl Colton
12:20 PM – Bispecifics to Treat Multiple Myeloma: Case and Discussion
Aaron Rosenberg and Guneet Kaleka, MD
1:10 PM – Putting All the Pieces Together: Summarizing Best Practices and Proposed Sequencing
Michael Green
1:30 PM – Conclusion
Ajai Chari
Description
Live interactive continuing medical education activity for healthcare professionals in San Francisco, Oakland, Palo Alto, Raleigh, Sacramento, and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with myeloma.
Educational Objectives
After completing this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
-
Engage patients and caregivers in clinical trials discussions on newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bispecific antibodies
-
Explain disparities and challengies in diagnosis and treatment of myeloma
-
Apply evidence-based treatment strategies for optimal patient care
-
Identify patient education and support resources
Advisory Group
Ajai Chari, MD (Chair)
University of California, San Francisco
San Francisco, CA
Richard L. Fong, PharmD, BCOP
University of California, San Francisco
San Francisco, CA
Michael Green, MD
Oakland Medical Center
Kaiser Permanente
Oakland, CA
Michaela Liedtke, MD
Stanford Medicine
Palo Alto, CA
Aaron Rosenberg, MD, MS
UC Davis Comprehensive Cancer Center
Sacramento, CA
Faculty
Ajai Chari, MD (Chair)
University of California, San Francisco
San Francisco, CA
Meryl Colton, MD, MSc
University of California, San Francisco
San Francisco, CA
Yonatan Cooper, MD, PhD
Stanford Medicine
Palo Alto, CA
Ashley Giacobbi, DNP, RN, ACNS-BS, AOCNS, OCN
The Leukemia & Lymphoma Society
Rye Brook, NY
Michael Green, MD
Oakland Medical Center
Kaiser Permanente
Oakland, CA
Guneet Kaleka, MD
UC Davis Comprehensive Cancer Center
Sacramento, CA
Jodi Lipof, MD
University of California, San Francisco
San Francisco, CA
Lekha Mikkilineni, MD, MA
Stanford Medicine
Palo Alto, CA
Aaron Rosenberg, MD, MS
UC Davis Comprehensive Cancer Center
Sacramento, CA
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supported by educational grants from Adaptive Biotechnologies Corporation and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: Profeducation@LLS.org.
